Transient Osteoporosis of Pregnancy: A Possible Peptide Mediator
|ClinicalTrials.gov Identifier: NCT00541645|
Recruitment Status : Suspended
First Posted : October 10, 2007
Last Update Posted : March 18, 2008
Transient osteoporosis of pregnancy (TOoP) is uncommonly encountered in orthopedic and obstetric practice, with most reports consisting of single cases.
This rare condition consists of significant osteoporosis affecting the hips and spine, causing significant morbidity, and putting young female patients at risk for vertebral and femoral neck fractures.
The pathogenesis of transient osteoporosis of pregnancy is unknown, with various theories as to its etiology.
Recently, a number of reports have described elevated levels of PTHrP in patients with transient osteoporosis in pregnancy and of the postpartum period Our goal in this study is to assess the role of PTHrP in transient osteoporosis of pregnancy
|Condition or disease|
|Study Type :||Observational|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00541645
|Principal Investigator:||Efrain Liebner, MD||Hadassah Medical Organization|
|Study Chair:||Meir Liebergall, M.D||Hadassah Medical Organization|
|Study Director:||Tzvi Bar-Shavit, Ph.D||The Hebrew University|